MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Wilson’s Disease About A Complex Case

    A. Ouedraogo, V. Ouedraogo, A. Savadogo (Bobo-Dioulasso, Burkina Faso)

    Objective: We report the case of a patient who experienced diagnostic wavering. Background: Wilson disease is a rare disease. Cases in Africa is even rarer.…
  • 2024 International Congress

    Dandy-Walker syndrome. A case study.

    GM. Mussagaliyeva (Almaty, Kazakhstan)

    Objective: Present a case study with rare congenital disease for further сreating a database and developing algorithms for the management of such cases in the…
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Preventing Medication Errors for Hospitalized People with Parkinson’s Disease – Results of Six Months of Proactive Intervention

    C. Piccinin, J. Yu, A. Brooks, V. Stepanyants, P. Clark, S. Shaffer, B. Sokola, K. Lewin, C. Sonneborn, O. Hogue, S. Sperling, H. Fernandez, W. Walter (Cleveland, USA)

    Objective: To determine whether a Parkinson’s disease (PD) Inpatient Program will prevent medication errors and ultimately improve the safety and quality of care for hospitalized…
  • 2024 International Congress

    Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

    B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)

    Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…
  • 2024 International Congress

    Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…
  • 2024 International Congress

    The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases

    J. Maple-Grødem, V. Frantzen, J. Lange, E. Fiske, E. Bjordal, V. Forsaa, ø. Kallevåg, J. Berge, A. Jimenez, P. Førland, D. Aarsland, G. Alves (Stavanger, Norway)

    Objective: The Pro-LBD cohort study is a prospective, long-term, clinic-biological cohort study of participants who are stratified by their risk of developing a Lewy body…
  • 2024 International Congress

    Levels of change in interleukin-6 levels according to clinical stages of Parkinson’s disease in patients with and without Covid-19

    R. Juraev, B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in clinical stages Parkinson's disease  patients with and without Сovid-19. Background: Elevated levels of the cytokine IL-6 may indicate…
  • 2024 International Congress

    Unraveling the Role of Short Tandem Repeats in Parkinson’s disease, Essential tremor, and Amyotrophic lateral sclerosis: A Large Chinese Cohort Study

    Y. Zhao, Z. Liu, H. Pan, Q. Sun, J. Wang, J. Guo, B. Tang (Changsha, China)

    Objective: This study investigates the prevalence and impact of short tandem repeat (STR) mutations in the next-generation sequencing data of patients with Parkinson’s disease (PD), essential…
  • 2024 International Congress

    Genetic Study of polymorphism of cytokines in Parkinson’s disease.

    S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The aim of our study was to conduct a cohort that demonstrates genetic variations in cytokines genes involved in the physiopathology, the development and…
  • « Previous Page
  • 1
  • …
  • 298
  • 299
  • 300
  • 301
  • 302
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley